Solar UV radiation-induced immunosuppression is a risk factor for nonmelanoma
skin cancer.
Interleukin (IL)-12 has been shown to possess antitumor activity and inhibit the immunosuppressive effects of UV radiation in mice. In this study, we generated
IL-12 knockout (KO) mice on a C3H/HeN background to characterize the role of
IL-12 in photocarcinogenesis. After exposure of the mice to UVB (180 mJ/cm2) radiation thrice a week for 35 weeks, the development of UV-induced
tumors was more rapid and the
tumor multiplicity and
tumor size were significantly higher in
IL-12 KO mice than their wild-type (WT) counterparts (P < 0.05-0.001). Moreover, the malignant transformation of UVB-induced
papillomas to
carcinomas was higher in
IL-12 KO mice in terms of
carcinoma incidence (55%, P < 0.001),
carcinoma multiplicity (77%, P < 0.001), and
carcinoma size (81%, P < 0.001). As
IL-12 has the ability to repair UV-induced DNA damage, we determined this effect in our in vivo
IL-12 KO mouse model. We found that UVB-induced DNA damage in the form of
cyclobutane pyrimidine dimers was removed or repaired more rapidly in WT mice than
IL-12 KO mice. Similarly, the UVB-induced
sunburn cell formation is primarily a consequence of DNA damage. It was observed that UVB-induced
sunburn cells were repaired rapidly in WT mice compared with
IL-12 KO mice. The rapid removal or repair of UV-induced
cyclobutane pyrimidine dimers or
sunburn cells will result in reduced risk of photocarcinogenesis. Taken together, our data show that
IL-12 deficiency is associated with the greater risk of photocarcinogenesis in mice, and this may be due to reduction in damaged DNA repair ability.